Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Anixa Biosciences Inc (ANIX)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Anixa Biosciences's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
3.120 +0.020    +0.65%
- Closed. Currency in USD ( Disclaimer )
After Hours
3.090
-0.030
-0.962%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 32,691
  • Bid/Ask: 3.090 / 3.400
  • Day's Range: 3.050 - 3.200
Anixa Biosciences 3.120 +0.020 +0.65%

Anixa Biosciences Inc Company Profile

 
Get an in-depth profile of Anixa Biosciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company’s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Contact Information

Address 3150 Almaden Expressway Suite 250
San Jose, 95118
United States
Phone 408 708 9808
Fax -
Web www.anixa.com

Top Executives

Name Age Since Title
Daniel Abate-Daga - 2018 Member of Scientific Advisory Board
H. Michael Shepard - - Member of Scientific Advisory Board
Linda L. Kelley 68 2018 Member of Scientific Advisory Board
Jose Conejo-Garcia - 2018 Member of Scientific Advisory Board
Marco L. Davila - 2018 Member of Scientific Advisory Board
Lewis H. Titterton 78 2012 Lead Independent Director
Ian Hector Frazer - 2019 Member of Scientific Advisory Board
Emily Gottschalk 62 2019 Independent Director
Hope S. Rugo - 2023 Member of Breast Cancer Clinical Advisory Board
Brian Czerniecki - 2023 Member of Breast Cancer Clinical Advisory Board
G. Thomas Budd - 2023 Member of Breast Cancer Clinical Advisory Board
Lisa H. Butterfield - 2023 Member of Breast Cancer Clinical Advisory Board
Brian Leyland-Jones 73 2023 Member of Breast Cancer Clinical Advisory Board
Karen E. Knudsen - 2023 Member of Cancer Business Advisory Board
Robert E. Youle - 2023 Member of Cancer Business Advisory Board
Daniel P. Heist - 2023 Member of Cancer Business Advisory Board
Len Lichtenfeld - 2023 Member of Cancer Business Advisory Board
Scarlott K. Mueller - 2023 Member of Cancer Business Advisory Board
Michael T. Marquardt - 2023 Member of Cancer Business Advisory Board
Gary M. Reedy - 2023 Member of Cancer Business Advisory Board
Arnold M. Baskies 74 2018 Member of SAB & Breast Cancer Clinical Advisory Board, Co-Chair of CBAB and Independent Director
Mark A. Goldberg 69 2023 Member of Cancer Business Advisory Board
Pamela D. Garzone 68 2021 Chief Development Officer & Chair Breast Cancer Clinical Advisory Board
Amit Kumar 60 2012 CEO, Chairman & Co-Chair of CBAB
Sanjay Juneja - 2024 Member of Cancer Business Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ANIX Comments

Write your thoughts about Anixa Biosciences Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Thomas Civiello
Thomas Civiello Jan 30, 2022 10:42PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Anixa will bust out as a lot going on inside this company
Reply
2 0
Report
Crude Bear
CrudeBear11 Apr 26, 2021 1:24PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
http://www.openinsider.com/ ANIX is listed as a recent "cluster buy"... someone bought 90,600 shares at $4.58. Not investment advice... Just pointing this out.
Reply
1 0
Report
Sep 15, 2020 10:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ding *******sing a song, time to go long like Ching Xhong with a *******in a thong
Reply
2 1
Report
Sep 15, 2020 10:34AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ignore that.. Just go long and wait 6+months for the magic... This could be a once in a century discovery here.. cash runway 16-24 months no debts what so ever, a CEO with great track record, DoD backing, Cleveland Clinic collobaration etc etc, just WOW. Let’s make a fortune. Do your own DD, but let’s face it - Won’t get much bettet then this RR wise... Glta
Reply
1 0
Report
Matt Applegate
Matt Applegate Jan 26, 2018 8:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Still holding
Reply
0 0
Report
Ryan Kyler
Ryan Kyler Jan 26, 2018 8:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Monday should be a very good day. Fingers crossed.
Reply
0 0
Report
Keenan Vick
Keenan Vick Jan 24, 2018 10:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Anyone still holding?
Reply
1 0
Report
Matt Applegate
Matt Applegate Jan 24, 2018 10:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Debating to sell, lot of drops .
Reply
0 0
Report
Steven Hufschmidt
Steven Hufschmidt Sep 26, 2017 1:05PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Falling like a friggin rock now.
Reply
0 0
Report
Steven Hufschmidt
Steven Hufschmidt Sep 26, 2017 1:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I shoulda sold it.
Reply
0 0
Report
Sam Car
Sam Car Sep 25, 2017 12:31PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Are u holding through Sept 27?
Reply
0 1
Report
Fernando Liriano
Fernando Liriano Sep 19, 2017 8:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I just made good money on this one
Reply
0 0
Report
Sam Car
Sam Car Sep 19, 2017 8:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Are u holding through sept 27?
Reply
0 0
Report
abc abc
abc abc Sep 19, 2017 8:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
good for you.!!!
Reply
0 0
Report
Fernando Liriano
Fernando Liriano Sep 19, 2017 8:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Í justo made gold money on this one
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email